1. Home
  2. Labeler Index
  3. Amneal Pharmaceuticals Llc
  4. 70121-1755
  5. NDC Package Code: 70121-1755-1 Alymsys

NDC Package 70121-1755-1 Alymsys

Bevacizumab-maly Injection, Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Other Packages
    4. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70121-1755-1
Package Description:
1 VIAL in 1 CARTON / 16 mL in 1 VIAL
Product Code:
70121-1755
Proprietary Name:
Alymsys
Non-Proprietary Name:
Bevacizumab-maly
Substance Name:
Bevacizumab
Usage Information:
This medication is a man-made antibody (IgG1) used to treat various types of cancer. This drug works by blocking a certain protein (vascular endothelial growth factor-VEGF) thereby decreasing the blood supply to the tumor and slowing tumor growth. This monograph is about the following bevacizumab products: bevacizumab, bevacizumab-awwb, and bevacizumab-bvzr.
11-Digit NDC Billing Format:
70121175501
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 2599043 - bevacizumab-maly 100 MG in 4 ML Injection
  • RxCUI: 2599043 - 4 ML bevacizumab-maly 25 MG/ML Injection
  • RxCUI: 2599043 - bevacizumab-maly 100 MG per 4 ML Injection
  • RxCUI: 2599043 - bevacizumab-maly 25 MG/ML per 4 ML Injection
  • RxCUI: 2599049 - Alymsys 100 MG in 4 ML Injection
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Amneal Pharmaceuticals Llc
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • BEVACIZUMAB 400 mg/16mL
    • Pharmacologic Class(es):
  • Vascular Endothelial Growth Factor Inhibitor - [EPC] (Established Pharmacologic Class)
  • Vascular Endothelial Growth Factor Inhibitors - [MoA] (Mechanism of Action)
  • Vascular Endothelial Growth Factor-directed Antibody Interactions - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    BLA761231
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    04-15-2022
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 70121-1755-1 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    70121175501Q5126Inj alymsys 10 mg10 MG1614040

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    70121-1755-710 VIAL in 1 CARTON / 16 mL in 1 VIAL

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 70121-1755-1?

    The NDC Packaged Code 70121-1755-1 is assigned to a package of 1 vial in 1 carton / 16 ml in 1 vial of Alymsys, a human prescription drug labeled by Amneal Pharmaceuticals Llc. The product's dosage form is injection, solution and is administered via intravenous form.

    Is NDC 70121-1755 included in the NDC Directory?

    Yes, Alymsys with product code 70121-1755 is active and included in the NDC Directory. The product was first marketed by Amneal Pharmaceuticals Llc on April 15, 2022 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 70121-1755-1?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 70121-1755-1?

    The 11-digit format is 70121175501. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-170121-1755-15-4-270121-1755-01